CO5210860A1 - Nuevos derivados de pirimidina-2,4,6-triona - Google Patents

Nuevos derivados de pirimidina-2,4,6-triona

Info

Publication number
CO5210860A1
CO5210860A1 CO00073355A CO00073355A CO5210860A1 CO 5210860 A1 CO5210860 A1 CO 5210860A1 CO 00073355 A CO00073355 A CO 00073355A CO 00073355 A CO00073355 A CO 00073355A CO 5210860 A1 CO5210860 A1 CO 5210860A1
Authority
CO
Colombia
Prior art keywords
pirimidina
triona
compounds
formula
new derivatives
Prior art date
Application number
CO00073355A
Other languages
English (en)
Inventor
Frank Grams
Hans-Willi Krell
Herbert Leinert
Ernesto Menta
Werner Zimmermann
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of CO5210860A1 publication Critical patent/CO5210860A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A61K31/515—Barbituric acids; Derivatives thereof, e.g. sodium pentobarbital
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Compuestos de fórmula<EMI FILE="00073355_1" ID="1" IMF=JPEG >en la cualR1 representa un radical fenilo, fenoxilo, feniltio, fenilsulfinilo, fenilsulfonilo, fenilamino o fenilmetilo, en donde la parte fenilo puede estar substituida con uno o más átomos de halógeno, hidroxilo, alcoxilo de 1 a 6 átomos de carbono, alquilo de 1 a 6 átomos de carbono, ciano o grupos nitro, yR2 representa un grupo arilo o heteroarilo opcionalmente substituido, así como sus sales farmacéuticamente aceptables de los compuestos de fórmula I.
CO00073355A 1999-10-01 2000-09-27 Nuevos derivados de pirimidina-2,4,6-triona CO5210860A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99119506 1999-10-01

Publications (1)

Publication Number Publication Date
CO5210860A1 true CO5210860A1 (es) 2002-10-30

Family

ID=8239103

Family Applications (1)

Application Number Title Priority Date Filing Date
CO00073355A CO5210860A1 (es) 1999-10-01 2000-09-27 Nuevos derivados de pirimidina-2,4,6-triona

Country Status (29)

Country Link
US (1) US6498252B1 (es)
EP (1) EP1226128B1 (es)
JP (1) JP3848160B2 (es)
KR (1) KR100459975B1 (es)
CN (1) CN1157382C (es)
AR (1) AR033651A1 (es)
AT (1) ATE289595T1 (es)
AU (1) AU768309B2 (es)
BR (1) BR0014678A (es)
CA (1) CA2385863C (es)
CO (1) CO5210860A1 (es)
CZ (1) CZ20021535A3 (es)
DE (1) DE60018301T2 (es)
ES (1) ES2235955T3 (es)
HK (1) HK1050198A1 (es)
HU (1) HUP0202832A3 (es)
IL (1) IL148573A0 (es)
MA (1) MA26823A1 (es)
MX (1) MXPA02003192A (es)
NO (1) NO20021380L (es)
NZ (1) NZ517635A (es)
PE (1) PE20010659A1 (es)
PL (1) PL202680B1 (es)
RU (1) RU2248971C2 (es)
TR (1) TR200200858T2 (es)
UY (1) UY26362A1 (es)
WO (1) WO2001025217A1 (es)
YU (1) YU22102A (es)
ZA (1) ZA200201754B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6716845B2 (en) 2001-03-30 2004-04-06 Hoffmann-La Roche Inc. Barbituric acid derivatives
US6936620B2 (en) 2001-12-20 2005-08-30 Bristol Myers Squibb Company Barbituric acid derivatives as inhibitors of TNF-α converting enzyme (TACE) and/or matrix metalloproteinases
WO2004084903A1 (en) * 2003-03-27 2004-10-07 F. Hoffmann-La Roche Ag Use of a trioxopyrimidine for the treatment and prevention of ocular pathologic angiogenesis
WO2004084902A1 (en) * 2003-03-28 2004-10-07 F. Hoffmann-La Roche Ag Use of a trioxopyrimidine for the treatment of chronic wounds
CN100558362C (zh) * 2004-04-01 2009-11-11 霍夫曼-拉罗奇有限公司 三氧嘧啶治疗和预防支气管炎症疾病的应用
KR100771411B1 (ko) * 2004-04-01 2007-10-30 에프. 호프만-라 로슈 아게 피리미딘-2,4,6-트리온의 시클로덱스트린 포접 복합체
EP1632489A1 (en) * 2004-08-24 2006-03-08 University of Liege 5-(1,1'-Biphenyl)-4-yl-5-(4-(4-aminoacylphenyl)-piperazin)-1-yl-pyrimidine-2,4,6-trione derivatives, as inhibitors of zinc metallondopeptidases, their preparation and use.
RU2449994C1 (ru) * 2011-03-10 2012-05-10 Светлана Алексеевна Мещерякова 6-(4-бензилпиперазино)-1,3-диметилурацила дигидрохлорид, проявляющий биологическую активность
RU2598607C1 (ru) * 2015-07-16 2016-09-27 Федеральное государственное бюджетное образовательное учреждение высшего образования "Астраханский государственный университет" (Астраханский государственный университет) Способ получения 5-гетарилметиленпиримидин-2,4,6-трионов

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1246743B (de) * 1965-01-12 1967-08-10 Dresden Arzneimittel Verfahren zur Herstellung von 5-Phenyl-5-piperidinobarbitursaeuren
US4595700A (en) 1984-12-21 1986-06-17 G. D. Searle & Co. Thiol based collagenase inhibitors
GB8726714D0 (en) 1987-11-14 1987-12-16 Beecham Group Plc Compounds
GB8827305D0 (en) 1988-11-23 1988-12-29 British Bio Technology Compounds
US5239078A (en) 1990-11-21 1993-08-24 Glycomed Incorporated Matrix metalloprotease inhibitors
DE69108529T2 (de) 1990-12-03 1995-11-30 Celltech Therapeutics Ltd Peptidylderivate.
CA2058797A1 (en) 1991-02-01 1992-08-02 Michael John Broadhurst Amino acid derivatives
US5789434A (en) 1994-11-15 1998-08-04 Bayer Corporation Derivatives of substituted 4-biarylbutyric acid as matrix metalloprotease inhibitors
US6153757A (en) 1995-12-08 2000-11-28 Agouron Pharmaceuticals, Inc. Metalloproteinase inhibitors and intermediates useful for their preparation
DE19548624A1 (de) 1995-12-23 1997-06-26 Boehringer Mannheim Gmbh Neue Barbitursäure-Derivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
US6350786B1 (en) * 1998-09-22 2002-02-26 Hoffmann-La Roche Inc. Stable complexes of poorly soluble compounds in ionic polymers

Also Published As

Publication number Publication date
UY26362A1 (es) 2001-04-30
MXPA02003192A (es) 2002-09-30
HUP0202832A3 (en) 2003-03-28
WO2001025217A1 (en) 2001-04-12
BR0014678A (pt) 2002-07-23
AU768309B2 (en) 2003-12-04
DE60018301T2 (de) 2006-04-06
PL202680B1 (pl) 2009-07-31
KR20020039356A (ko) 2002-05-25
CN1157382C (zh) 2004-07-14
KR100459975B1 (ko) 2004-12-03
DE60018301D1 (de) 2005-03-31
AU7784900A (en) 2001-05-10
ATE289595T1 (de) 2005-03-15
NZ517635A (en) 2003-11-28
HUP0202832A2 (hu) 2003-02-28
JP3848160B2 (ja) 2006-11-22
TR200200858T2 (tr) 2002-07-22
CZ20021535A3 (cs) 2002-11-13
AR033651A1 (es) 2004-01-07
MA26823A1 (fr) 2004-12-20
CN1374954A (zh) 2002-10-16
EP1226128A1 (en) 2002-07-31
NO20021380D0 (no) 2002-03-20
HK1050198A1 (en) 2003-06-13
NO20021380L (no) 2002-03-20
YU22102A (sh) 2004-11-25
EP1226128B1 (en) 2005-02-23
PL357385A1 (en) 2004-07-26
CA2385863A1 (en) 2001-04-12
IL148573A0 (en) 2002-09-12
CA2385863C (en) 2009-04-14
RU2248971C2 (ru) 2005-03-27
ZA200201754B (en) 2003-06-02
ES2235955T3 (es) 2005-07-16
PE20010659A1 (es) 2001-06-20
JP2003511376A (ja) 2003-03-25
US6498252B1 (en) 2002-12-24

Similar Documents

Publication Publication Date Title
CO5180557A1 (es) Derivados de 1,4-diazabiciclo[3.2.2]nonan-4-carboxilatos y carboxamidas y sus composiciones farmaceuticas .
DK0931788T3 (da) Metalloproteasehæmmere
CO5261539A1 (es) Compuestos farmaceuticamente activos
CO5261497A1 (es) Gama-hidroxi-2-(fluoroalquilamino-carbonil)-1-piperazino pentanamidas y sus usos
CO5140093A1 (es) Epotilonas c 21 modificadas
NO983970L (no) Tricykliske forbindelser, deres fremstilling og anvendelse
CY1117930T1 (el) Ανασετραπιμπη και αλλοι αναστολεις cetp
CO4970713A1 (es) Derivados de carboxamidotiazoles, su preparacion, composiciones farmaceuticas que los contienen
CA2347512A1 (en) Adenine derivatives
DK1204654T3 (da) Benzofurylpiperaziner og benzofurylhomopiperaziner: Serotonin agonister
CO5150182A1 (es) Compuestos de triazol y su utilizacion
CO5210884A1 (es) DERIVADOS DE 5H-TIAZOLO[3,2-a] PIRIMIDINA
CO5271675A1 (es) Derivados de decahidro-isoquinolinas, proceso para su preparacion, composicion y compuestos farmaceuticos que los contienen
CO5271716A1 (es) Cristales de 4- carboxamino 1,2,3,4-tetrahidroquinolina 2- sustituida
CO5210860A1 (es) Nuevos derivados de pirimidina-2,4,6-triona
CO5261566A1 (es) Compuestos antipicornavirales y composiciones, sus usos farmaceuticos y materiales para su sintesis
DE69432497T2 (de) Akridinium Derivate und deren Konjugate
CO5180544A1 (es) Derivados de mononitrato de tiocarboxilatos y piridil-mercapto-carboxilatos de isosorbida
EA200000975A1 (ru) 6-(2-гало-4-алкоксифенил)триазолпиримидины с фунгицидным действием
CO5210883A1 (es) DERIVADOS DE 4-OXO-3,5-DIHIDRO-4H-PIRIDAZINO [4,5,-b]INDOL- 1-ACETAMIDA
CO5200762A1 (es) Preparacion de piperidin-4-onas sustituidas
CO5261594A1 (es) Inhibidores de myt1 cinasa
BR0013075A (pt) Derivados de tetrazolinona
FI912888A (fi) 2-(aminoalkyl)-5-(arylalkyl)-1,3 -dioxanderivat, deras framstaellning och terapeutiska tillaempning.
ATE229996T1 (de) Starkes grünstichiges gelbes disazopigment

Legal Events

Date Code Title Description
FC Application refused